Pilot program by IU and Davos Alzheimer’s Collaborative to test AI-powered cognitive screening at scale

How AI, Dig­i­tal Screen­ing Tools Can Help Flag Ear­ly Cog­ni­tive Decline (Health IT Ana­lyt­ics): Ear­ly diag­no­sis of Alzheimer’s and oth­er demen­tias remains at the fore­front of efforts to min­i­mize the impact of these neu­rode­gen­er­a­tive dis­eases. But chal­lenges such as increased life expectan­cy and the risks of aging, along with com­plex­i­ties in diag­no­sis and treat­ment resulting…

Read More

Study finds ADHD is associated with dementia

Multi­gen­er­a­tional Study Finds Links Between ADHD, Demen­tia Risk (Health Day): Atten­­tion-deficit/hy­per­ac­­tiv­i­­ty dis­or­der (ADHD) appears to be some­how linked to risk of demen­tia and Alzheimer’s dis­ease, a new multi­gen­er­a­tional study has found. Par­ents and grand­par­ents of peo­ple with ADHD have a high­er risk of Alzheimer’s and demen­tia than peo­ple with no ADHD in their fam­i­ly, Swedish researchers…

Read More

Neurostimulation device GammaSense by Cognito Therapeutics secures FDA Breakthrough Device Designation to explore Alzheimer’s Disease applications

Cog­ni­to Ther­a­peu­tics nets FDA break­through label for light, sound ther­a­py for Alzheimer’s dis­ease (Fierce Biotech): Using spe­cif­ic fre­quen­cies of flash­ing lights and sounds to stim­u­late the brain’s elec­tri­cal activ­i­ty, Cog­ni­to Ther­a­peu­tics believes it can help treat Alzheimer’s dis­ease by ener­giz­ing neu­rons and reac­ti­vat­ing the immune system.

Read More

September 17th @ UC Berkeley: Disrupting neurodegenerative diseases

__________ Quick heads-up about a great event next month for those based in the San Fran­cis­co Bay Area. When: Tues­day, Sep­tem­ber 17, 2019 / 8:30 AM – 6:00 PM PDT Where: Pauley Ball­room, UC Berke­ley What: 2019 UC Berke­ley Aging Research & Tech­nol­o­gy Sum­mit: Dis­rupt­ing Neu­rode­gen­er­a­tive Dis­eases Alzheimer’s and neu­rode­gen­er­a­tive dis­eases are

Read More

The World Economic Forum hosts Global Future Council on Neurotechnologies in Dubai (November 10–12th)

Quick heads-up on a very promis­ing event. Descrip­tion: Quick­ly devel­op­ing neu­rotech­nolo­gies will have an impact on entire indus­tries, gov­ern­ments, and soci­eties in the future. The Glob­al Future Coun­cil on Neu­rotech­nolo­gies will explore these tech­no­log­i­cal devel­op­ments and their eth­i­cal impli­ca­tions for society. 

Read More

News: Advanced Brain Monitoring receives Global Health and Pharma Award for clinical-grade platforms monitoring brain’s electrical activity

— Advanced Brain Mon­i­tor­ing Named “Most Inno­v­a­tive Med­ical Device Com­pa­ny” at Glob­al Health and Phar­ma Awards (Sleep Review): “Advanced Brain Mon­i­tor­ing Inc was named the “Most Inno­v­a­tive Med­ical Device Com­pa­ny” by Glob­al Health and Phar­ma at its 2016 Health­care and Phar­ma­ceu­ti­cal awards. “This award rec­og­nizes our company’s suc­cess­es in devel­op­ing tech­nolo­gies which enable clin­i­cians and…

Read More